C000075819 Performance — MetLife Stock Index Portfolio, Class D

Data updated: 2026-08-27

C000075819 returned +10.00% year to date and +21.88% over one year to Jun 2026. Annualised returns are +20.18% over 3 years and +13.00% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $174, against $157 for the category, and to $122 over one year, against $118. Volatility over the past three years was 13.05% a year. In the 12 months to Jun 2026 the fund took in a net $82.0M, and assets reached $9.70B.

C000075819 Growth of $100

What $100 invested in MetLife Stock Index Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.

PeriodC000075819Category average
1 year (Jul 2025 – Jun 2026)$122$118
3 years (Jul 2023 – Jun 2026)$174$157
5 years (Jul 2021 – Jun 2026)$184$161
Since data start (Jul 2019 – Jun 2026)$277$229

C000075819 Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+10.00%
1 year+21.88%
3 years (annualised)+20.18%
5 years (annualised)+13.00%

C000075819 Annual Returns

Calendar-year total returns of MetLife Stock Index Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jun)+10.00%
2025+17.48%
2024+24.58%
2023+25.79%
2022−18.39%
2021+28.24%
2020+17.99%
2019 (Jul–Dec)+10.74%

C000075819 Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+1.4%−0.8%−5.0%+10.4%+5.2%−1.0%——————
2025+2.8%−1.3%−5.7%−0.7%+6.3%+5.1%+2.2%+2.0%+3.6%+2.3%+0.2%0.0%
2024+1.7%+5.3%+3.2%−4.1%+4.9%+3.5%+1.2%+2.4%+2.1%−0.9%+5.8%−2.4%
2023+6.2%−2.5%+3.6%+1.5%+0.4%+6.6%+3.2%−1.6%−4.8%−2.1%+9.1%+4.5%
2022−5.2%−3.0%+3.7%−8.7%+0.1%−8.3%+9.2%−4.1%−9.2%+8.1%+5.5%−5.8%
2021−1.0%+2.7%+4.3%+5.3%+0.7%+2.3%+2.4%+3.0%−4.7%+7.0%−0.7%+4.5%
2020−0.1%−8.2%−12.4%+12.8%+4.7%+2.0%+5.6%+7.1%−3.8%−2.7%+10.9%+3.8%
2019——————+1.4%−1.6%+1.8%+2.1%+3.6%+3.0%

C000075819 Risk

Risk measures from monthly returns over Jul 2023 – Jun 2026.

  • 3-year volatility (annualised): 13.05%
  • 3-year Sharpe ratio: 1.20 (vs 4.5% risk-free rate)
  • Best month: +10.45% (Apr 2026)
  • Worst month: −5.66% (Mar 2025)

C000075819 Fund Flows

Monthly money in and out of MetLife Stock Index Portfolio, from SEC Form N-PORT.

  • 12-month net flow: $82.0M
  • 12-month gross sales (incl. reinvestments): $1.5B
  • Sales ÷ redemptions: 1.06×
MonthSalesRedemptionsNet flow
Jun 2026$1.1B$127.6M$995.1M
May 2026$10.6M$132.6M−$122.0M
Apr 2026$93.9M$119.1M−$25.1M
Mar 2026$28.6M$80.5M−$51.9M
Feb 2026$9.2M$79.4M−$70.2M
Jan 2026$28.6M$103.7M−$75.0M
Dec 2025$7.8M$113.3M−$105.5M
Nov 2025$6.6M$109.5M−$102.9M
Oct 2025$10.1M$128.9M−$118.8M
Sep 2025$7.1M$128.7M−$121.6M
Aug 2025$10.4M$169.2M−$158.8M
Jul 2025$193.6M$154.8M$38.8M

C000075819 Assets Under Management

Net assets of MetLife Stock Index Portfolio by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$9.70B
2026-03-31$8.66B
2025-12-31$9.26B
2025-09-30$9.35B
2025-06-30$8.88B
2025-03-31$8.43B
2024-12-31$8.91B
2024-09-30$8.23B
2024-06-30$8.01B
2024-03-31$7.96B
2023-12-31$7.45B
2023-09-30$6.88B

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.